India · Delayed Price · Currency is INR Mukka Proteins Statistics
Total Valuation
Mukka Proteins has a market cap or net worth of INR 8.08 billion. The enterprise value is 15.77 billion.
| Market Cap | 8.08B |
| Enterprise Value | 15.77B |
Important Dates
The last earnings date was Saturday, November 7, 2026.
| Earnings Date | Nov 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Mukka Proteins has 300.00 million shares outstanding. The number of shares has increased by 1.45% in one year.
| Current Share Class | 300.00M |
| Shares Outstanding | 300.00M |
| Shares Change (YoY) | +1.45% |
| Shares Change (QoQ) | +0.60% |
| Owned by Insiders (%) | 73.33% |
| Owned by Institutions (%) | 3.97% |
| Float | 80.00M |
Valuation Ratios
The trailing PE ratio is 10.24.
| PE Ratio | 10.24 |
| Forward PE | n/a |
| PS Ratio | 0.40 |
| PB Ratio | 1.55 |
| P/TBV Ratio | 1.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 19.96 |
| EV / Sales | 0.78 |
| EV / EBITDA | 9.24 |
| EV / EBIT | 10.22 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 1.61.
| Current Ratio | 1.27 |
| Quick Ratio | 0.32 |
| Debt / Equity | 1.61 |
| Debt / EBITDA | 4.97 |
| Debt / FCF | n/a |
| Interest Coverage | 3.48 |
Financial Efficiency
Return on equity (ROE) is 17.16% and return on invested capital (ROIC) is 8.69%.
| Return on Equity (ROE) | 17.16% |
| Return on Assets (ROA) | 6.23% |
| Return on Invested Capital (ROIC) | 8.69% |
| Return on Capital Employed (ROCE) | 23.36% |
| Weighted Average Cost of Capital (WACC) | 5.66% |
| Revenue Per Employee | 56.84M |
| Profits Per Employee | 2.22M |
| Employee Count | 358 |
| Asset Turnover | 1.31 |
| Inventory Turnover | 1.96 |
Taxes
In the past 12 months, Mukka Proteins has paid 332.80 million in taxes.
| Income Tax | 332.80M |
| Effective Tax Rate | 28.14% |
Stock Price Statistics
The stock price has increased by +13.47% in the last 52 weeks. The beta is 0.62, so Mukka Proteins's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | +13.47% |
| 50-Day Moving Average | 27.20 |
| 200-Day Moving Average | 24.29 |
| Relative Strength Index (RSI) | 55.56 |
| Average Volume (20 Days) | 223,327 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Mukka Proteins had revenue of INR 20.35 billion and earned 795.37 million in profits. Earnings per share was 2.63.
| Revenue | 20.35B |
| Gross Profit | 3.79B |
| Operating Income | 1.55B |
| Pretax Income | 1.18B |
| Net Income | 795.37M |
| EBITDA | 1.71B |
| EBIT | 1.55B |
| Earnings Per Share (EPS) | 2.63 |
Balance Sheet
The company has 715.34 million in cash and 8.50 billion in debt, with a net cash position of -7.79 billion or -25.96 per share.
| Cash & Cash Equivalents | 715.34M |
| Total Debt | 8.50B |
| Net Cash | -7.79B |
| Net Cash Per Share | -25.96 |
| Equity (Book Value) | 5.28B |
| Book Value Per Share | 17.84 |
| Working Capital | 3.28B |
Cash Flow
In the last 12 months, operating cash flow was -14.76 million and capital expenditures -1.31 billion, giving a free cash flow of -1.33 billion.
| Operating Cash Flow | -14.76M |
| Capital Expenditures | -1.31B |
| Depreciation & Amortization | 165.53M |
| Net Borrowing | 2.33B |
| Free Cash Flow | -1.33B |
| FCF Per Share | -4.42 |
Margins
Gross margin is 18.64%, with operating and profit margins of 7.60% and 3.91%.
| Gross Margin | 18.64% |
| Operating Margin | 7.60% |
| Pretax Margin | 5.81% |
| Profit Margin | 3.91% |
| EBITDA Margin | 8.41% |
| EBIT Margin | 7.60% |
| FCF Margin | n/a |
Dividends & Yields
Mukka Proteins does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.45% |
| Shareholder Yield | -1.45% |
| Earnings Yield | 9.77% |
| FCF Yield | -16.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |